Nadine Besson

President

Nadine Besson bridges scientific innovation and commercial impact, translating complex breakthroughs into market-leading assets. With over 15 years of experience across the biopharma value chain, she has launched clinical oncology programs at Pfizer, led strategic planning for multi-billion-dollar franchises at Roche/Genentech, and pioneered external innovation and strategic partnering at Gilead.

Fluent in both the language of the lab and the boardroom, Nadine helps organizations navigate critical inflection points, including R&D portfolio strategy, commercial readiness, enterprise strategic planning, and organizational transformation.

Today, Nadine advises biotech and pharmaceutical leaders on their most complex challenges, delivering pragmatic, forward-looking solutions that drive sustainable impact.

Nadine holds a Master of Science in Biochemistry from Université Paris 7 and a Master’s degree in Biopharma Management from ESCP Europe Business School.